10-Q: Non-Invasive Monitoring Systems Reports Deepening Deficit and Going Concern Doubts in Q3 Filing

Non-Invasive Monitoring Systems, Inc. (NIMS) reported continued net losses and a deepening accumulated deficit in its latest quarterly filing, raising substantial doubt about its ability to continue as a going concern while operating as a shell company.

Summary

• Non-Invasive Monitoring Systems, Inc. (NIMS) filed its Form 10-Q for the quarter ended April 30, 2025, revealing ongoing financial distress and its status as a shell company.
• The company has discontinued its primary operations since May 2019 and has no current plans to develop or market new products, nor does it have inventory.
• NIMS reported a net loss of $42,000 for the three months ended April 30, 2025, and $161,000 for the nine months ended April 30, 2025.
• The accumulated deficit reached approximately $29,008,000 as of April 30, 2025, an increase from $28,847,000 at July 31, 2024.
• Cash on hand was critically low at $16,000 as of April 30, 2025, down from $25,000 at July 31, 2024.
• Total liabilities increased to $911,000 as of April 30, 2025, from $759,000 at July 31, 2024, primarily due to an increase in notes payable and accrued interest to related parties.
• The company has a shareholders deficit of approximately $886,000 as of April 30, 2025.
• Management explicitly stated that the cash on hand is not sufficient to meet anticipated cash requirements for the next 12 months, raising substantial doubt about the company's ability to continue as a going concern.
• Material weaknesses in internal control over financial reporting and disclosure controls were identified, citing insufficient segregation of duties and undocumented control procedures.

Sentiment

Score: 2

Explanation: The company is a shell with no operations, has a significant accumulated deficit, critically low cash, and explicitly states substantial doubt about its ability to continue as a going concern. While net losses decreased slightly, the overall financial health is extremely poor, and it relies heavily on related-party financing. Material weaknesses in internal controls further compound the negative outlook.

Positives

• Net loss for the nine months ended April 30, 2025, decreased to $161,000 from $186,000 in the prior year period, primarily due to a reduction in professional fees and insurance expense.
• General and administrative costs decreased to $115,000 for the nine months ended April 30, 2025, from $146,000 in the prior year period.
• Net cash used in operating activities decreased to $104,000 for the nine months ended April 30, 2025, from $143,000 in the prior year period.

Negatives

• The company has an accumulated deficit of approximately $29,008,000 as of April 30, 2025.
• Cash on hand is critically low at $16,000 as of April 30, 2025, which management believes is insufficient for the next 12 months.
• Total liabilities increased significantly to $911,000 as of April 30, 2025, driven by increased related-party debt.
• The company has a shareholders deficit of $886,000.
• The company is a shell company with no current operations, inventory, or plans to develop new products.
• Management identified material weaknesses in internal control over financial reporting and disclosure controls and procedures, citing insufficient segregation of duties and undocumented control procedures.

Risks

• Substantial doubt about the company's ability to continue as a going concern due to continuous net losses, cash outflows, and insufficient liquidity.
• Dependence on obtaining additional external financing (equity offerings, debt financings from shareholders, or collaborative agreements) to meet future cash requirements.
• Potential for significant dilution to stockholders if additional equity or convertible debt securities are issued.
• Continued instability in economic conditions may limit the company's ability to access capital in a timely manner.
• Material weaknesses in internal control over financial reporting, including insufficient segregation of duties and undocumented control procedures, which could lead to material misstatements in financial statements.
• History of operating losses and a significant accumulated deficit.

Future Outlook

The company expects to incur losses for the foreseeable future and believes that its current cash on hand is not sufficient to meet anticipated cash requirements for the next 12 months. It is likely that additional external financing will be required through public or private equity offerings, debt financings from shareholders, or collaborative agreements. The company is also assessing potential mergers, acquisitions, strategic collaborations, and liquidation.

Management Comments

• "The Company is currently a shell company (as defined in Rule 12b-2 of the Exchange Act)."
• "The Company maintains limited administration, but does not have any operations or inventory."
• "The Company has no inventory, no immediate plans to replenish inventory and has no current plans to develop or market new products."
• "These matters [net losses, cash outflows, accumulated deficit, low cash, shareholders deficit] raise substantial doubt about the Companys ability to continue as a going concern."
• "The Company is seeking potential mergers, acquisitions and strategic collaborations. The Company is also exploring obtaining additional promissory notes from related parties."
• "There is no assurance that the Company will be successful in this regard, and, if not successful, that it will be able to continue its business."
• "We believe that the cash on hand at April 30, 2025 is not sufficient to meet our anticipated cash requirements for the next 12 months."
• "We expect to incur losses for the foreseeable future."
• "It is likely that we will be required to obtain additional external financing through public or private equity offerings, debt financings from shareholders or collaborative agreements."
• "Management has concluded that the Company did not maintain effective internal control over financial reporting as of April 30, 2025 based on criteria established in Internal ControlIntegrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO)."
• "Notwithstanding the existence of these material weaknesses in the Companys internal control over financial reporting, the Companys management believes that the condensed consolidated financial statements included in this Form 10-Q fairly present in all material respects the Companys financial condition, results of operations and cash flows for the periods presented."

Industry Context

Non-Invasive Monitoring Systems, Inc. operates as a shell company, having discontinued its core business of developing and marketing whole body periodic acceleration (WBPA) therapeutic platforms in 2019. This places the company outside of any active industry trends, as it has no ongoing operations, products, or revenue streams. Its current activities are limited to administrative functions and seeking strategic alternatives, including potential mergers, acquisitions, or liquidation, which is typical for distressed or non-operational entities rather than active participants in the medical device or biotechnology sectors it once aimed to serve.

Comparison to Industry Standards

• Unlike active companies in the medical device or biotechnology sectors, NIMS has no comparable operational metrics such as revenue, R&D spending, or product pipeline progress, as it ceased operations in 2019.
• Its financial position, characterized by an accumulated deficit of $29.0 million and minimal cash of $16,000, is indicative of a company in severe financial distress, far below the liquidity and solvency benchmarks of healthy, operating companies.
• The reliance on related-party promissory notes for financing, totaling $595,000, is a common characteristic of shell companies or those struggling to secure traditional financing, unlike established industry players that access broader capital markets.
• The identified material weaknesses in internal controls, particularly regarding segregation of duties and undocumented procedures, fall significantly short of corporate governance standards expected of publicly traded companies, regardless of size or operational status.

Corporate Governance

Related Party Transactions

• The company is provided office space in Miami, Florida, on a month-to-month basis at no cost by a company controlled by Dr. Phillip Frost, a director and beneficial owner of over 10% of common stock.
• The company's Chief Financial Officer also serves as the Chief Financial Officer and Co-Chief Executive Officer of Cocrystal Pharma, Inc., a Nasdaq-listed biotechnology company where Dr. Frost serves on the Board.
• Outstanding notes payable to Frost Gamma Investments Trust (controlled by Dr. Phillip Frost) totaling $445,000 as of April 30, 2025, accruing interest at 11% per annum, due July 31, 2025. This includes new notes totaling $95,000 issued between September 2024 and January 2025.
• Outstanding notes payable to Dr. Jane Hsiao (Chairman and Interim CEO, beneficial owner of over 10% of common stock) totaling $150,000 as of April 30, 2025, accruing interest at 11% per annum, due July 31, 2025.
• Accrued interest on related party notes increased to $144,000 as of April 30, 2025.

Stakeholder Impact

• Shareholders face significant risk of dilution from potential future equity offerings. Existing shares are subject to substantial doubt about the company's ability to continue as a going concern and are held in a company with no active operations and a large accumulated deficit.
• Creditors (Related Parties) are the primary source of financing through promissory notes, indicating their continued support but also their exposure to the company's financial distress.
• Employees are minimally impacted as the company has limited administration and no operations.
• Customers and suppliers are not directly impacted as the company has no operations, inventory, or plans for new products.

Next Steps

• Seeking potential mergers, acquisitions, and strategic collaborations.
• Exploring obtaining additional promissory notes from related parties.
• Obtaining additional external financing through public or private equity offerings, debt financings from shareholders, or collaborative agreements.
• Addressing material weaknesses in internal control over financial reporting.

Key Dates

Recommendation

Keywords

NIMS, Non-Invasive Monitoring Systems, 10-Q, Quarterly Report, Shell Company, Going Concern, Financial Distress, Accumulated Deficit, Related Party Debt, Internal Control Weaknesses, Liquidity Crisis, OTC Pink, WBPA technology, Exer-Rest